Saptak Chem Raises ₹1.58 Cr Cash Through 20 Lakh Share Allotment

Saptak Chem And Business Limited has issued 20,00,000 fully paid-up equity shares following the conversion of warrants by non-promoter holders. This transaction injected ₹1.58 crore in cash into the company.

The capital infusion has significantly increased Saptak Chem's paid-up equity capital. It grew from ₹1.07 crore to ₹3.07 crore, reflecting a ₹2.00 crore rise. The total number of outstanding equity shares has expanded from 10,73,227 to 30,73,227. The newly issued shares hold the same rights as existing ones.

Warrant Conversion Details

The allotment, dated April 6, 2026, occurred after warrant holders outside the promoter group exercised their conversion rights. The company received ₹157.50 lakh (₹1.58 crore) in cash from this conversion. The face value of each share is ₹10.

Financial Impact and Significance

This capital injection strengthens Saptak Chem's financial position, providing funds that can be used for operations or debt management. An increased paid-up capital typically enhances a company's balance sheet and investment profile.

Origin of the Warrants

These warrants originated from a preferential issue approved on January 13, 2026. Saptak Chem had then agreed to allot 40,00,000 convertible equity warrants at ₹10.50 per warrant to non-promoter investors, aiming to raise ₹4.20 crore. The company had received an initial 25% payment, totaling ₹1.05 crore, for these warrants, which were convertible within 18 months.

Key Changes for Shareholders

The issuance of new shares means shareholders will see a larger equity base for Saptak Chem. The increased total number of shares outstanding could also affect earnings per share (EPS) calculations. This conversion represents a significant part of the company's earlier capital-raising efforts.

Remaining Warrant Obligations

While 20 lakh warrants have now been converted, Saptak Chem still has 20,00,000 warrants outstanding. These must be converted by paying the remaining exercise price within their 18-month deadline, which is expected around July 2027. Failure to convert these could affect future capitalisation plans.

Sector Context

Saptak Chem operates in the chemicals and agricultural produce trading sectors. Companies in these areas frequently raise capital to support growth or working capital. Similar companies like Lloyds Enterprises Ltd. and Tahmar Enterprises Ltd. also engage in such financial activities.

What to Track Next

Investors will likely monitor the conversion of the remaining 20,00,000 warrants before their expiry around July 2027. Observing how Saptak Chem utilizes the newly infused capital for business growth will also be key. Future announcements regarding financial performance or further capital-raising efforts will be important for tracking the company's progress.